Roivant Sciences (ROIV) Change in Account Payables (2020 - 2026)

Roivant Sciences (ROIV) has reported Change in Account Payables for 7 consecutive years, with $7.1 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Change in Account Payables rose 160.53% year-over-year to $7.1 million; the trailing twelve-month figure through Jun 2026 stood at -$14.4 million (up 69.93% YoY), and the FY2026 full-year result was $3.4 million, up 118.81% from the prior year.
• Change in Account Payables advanced to $7.1 million in Q2 2026 per ROIV's latest filing, from -$12.7 million in the prior quarter.
• Across five years, Change in Account Payables topped out at $26.2 million in Q3 2022 and bottomed at -$25.3 million in Q2 2024.
• Historically, Change in Account Payables has averaged -$1.4 million across 5 years, with a median of $1.8 million in 2023.
• The widest YoY moves for Change in Account Payables: up 501.0% in 2024, down 1101.84% in 2024.
• Over 5 years, Change in Account Payables stood at $14.0 million in 2022, then sank by 87.14% to $1.8 million in 2023, then plunged by 1101.84% to -$18.0 million in 2024, then gained by 29.25% to -$12.7 million in 2025, then soared by 155.81% to $7.1 million in 2026.
• According to Business Quant data, Change in Account Payables over the past three periods registered $7.1 million, -$12.7 million, and $3.0 million for Q2 2026, Q4 2025, and Q3 2025 respectively.